Biodexa Pharmaceuticals plc American Depositary Shs

XNAS

Last traded price · USD

$2.80

+4.09%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 15:26 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $2.69
Volume: 519
Day's high: —
Day's low: —

In brief

Biodexa Pharmaceuticals plc American Depositary Shs is a US-listed company listed on Nasdaq, valued at about $771,484.
Its shares closed at $2.69 on 4 Nov 2026, down 98.8% over the past year.
From India you can buy BDRX in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole BDRX share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade BDRX options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Set a 52-week low on 4 Nov 2026
Closed at $2.69 on 4 Nov 2026: 99.2% below the 52-week high of $357.60 (8 Dec 2025) and 0.0% above the low of $2.69 (4 Nov 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Behind SPY over 1 year
1 month: −43.5% (SPY −1.6%). 3 months: −78.9% (SPY −0.4%). 1 year: −98.8% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: BDRX, SPY · as of 4 Nov 2026
Short interest at 175.5% of shares outstanding
919.9K shares were sold short at the 15 Oct 2026 settlement, 175.5% of the 524.2K shares outstanding; covering them would take 1.0 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Below its 50- and 200-day averages
The 4 Nov 2026 close of $2.69 was 47.9% below its 50-day average ($5.16) and 88.8% below its 200-day average ($24.08).
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−43.5%

6 months−92.4%

1 year−98.8%

5 years—

Newswire

About

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Website

Notable moves

September 11, 2026
+96.94%
May 21, 2024
+83.46%
March 28, 2024
+88.59%

Biodexa Pharmaceuticals plc American Depositary Shs

XNAS

Last traded price · USD

$2.80

+4.09%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 15:26 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $2.69
Volume: 519
Day's high: —
Day's low: —

In brief

Biodexa Pharmaceuticals plc American Depositary Shs is a US-listed company listed on Nasdaq, valued at about $771,484.
Its shares closed at $2.69 on 4 Nov 2026, down 98.8% over the past year.
From India you can buy BDRX in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) shares from India?

Do I need the price of a whole BDRX share to invest?

How much can I invest in US stocks in a year?

Can I trade BDRX options or futures?

Insights

Quotes run fifteen minutes behind.

Set a 52-week low on 4 Nov 2026
Closed at $2.69 on 4 Nov 2026: 99.2% below the 52-week high of $357.60 (8 Dec 2025) and 0.0% above the low of $2.69 (4 Nov 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Behind SPY over 1 year
1 month: −43.5% (SPY −1.6%). 3 months: −78.9% (SPY −0.4%). 1 year: −98.8% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: BDRX, SPY · as of 4 Nov 2026
Short interest at 175.5% of shares outstanding
919.9K shares were sold short at the 15 Oct 2026 settlement, 175.5% of the 524.2K shares outstanding; covering them would take 1.0 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Below its 50- and 200-day averages
The 4 Nov 2026 close of $2.69 was 47.9% below its 50-day average ($5.16) and 88.8% below its 200-day average ($24.08).
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month−43.5%

6 months−92.4%

1 year−98.8%

5 years—

Newswire

About

Website

Notable moves

September 11, 2026
+96.94%
May 21, 2024
+83.46%
March 28, 2024
+88.59%

Biodexa Pharmaceuticals plc American Depositary Shs

Biodexa Pharmaceuticals plc American Depositary Shs in brief

Set a 52-week low on 4 Nov 2026

Behind SPY over 1 year

Short interest at 175.5% of shares outstanding

Below its 50- and 200-day averages

Biodexa Pharmaceuticals plc American Depositary Shs

Biodexa Pharmaceuticals plc American Depositary Shs in brief

Set a 52-week low on 4 Nov 2026

Behind SPY over 1 year

Short interest at 175.5% of shares outstanding

Below its 50- and 200-day averages